SARA SUTTON-MEYER: Open Payments
NPI 1457911075 · BURGAW, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 23 payments from 11 companies in 2025. Trend: 2023 $357 · 2024 $317 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Amgen Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| Medtronic, Inc. | 1 | $37 |
| Viatris Specialty LLC | 1 | $35 |
| ABBVIE INC. | 2 | $34 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Wegovy, REPATHA, MOUNJARO, VANTA ADAPTIVESTIM, YUPELRI, VRAYLAR, FARXIGA, BEYFORTUS.
Industry payments across NC — which companies pay providers there.
